The automated biochemical analyzers market was valued at $7.6 billion in 2023, and is projected to reach $24.1 billion by 2033, growing at a CAGR of 12.2% from 2024 to 2033.
An automated biochemical analyzer is a laboratory device designed to conduct biochemical tests on various biologocal samples, including blood, urine, or other bodily fluids, thus serving as an essential part of modern clinical laboratories. These analyzers automate the measurement of chemical components such as glucose, proteins, enzymes, and electrolytes, which are essential for diagnosing diseases, monitoring patient health, and guiding treatment decisions.
The growth of the global automated biochemical analyzers market is majorly driven by alarming increase in incidence of chronic conditions like diabetes, cardiovascular diseases, and kidney disorders. According to a study published by the World Health Organization in September 2023, approximately 41 million individuals die each year due to chronic diseases. This growing patient population necessitates frequent biochemical tests, such as glucose and lipid profile assessments, thus driving the demand for automated biochemical analyzers. Furthermore, surge in geriatric population significantly contributes toward the growth of the global market.
As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050. As the global population ages, there is a growing demand for diagnostic tests to monitor age-related diseases and conditions. Automated biochemical analyzers provide a high-throughput solution to manage the increasing workload in diagnostic laboratories.
In addition, rise in trend toward decentralized healthcare and point-of-care testing has increased the demand for compact, automated biochemical analyzers that can provide rapid results in non-laboratory settings such as clinics and emergency rooms. With the growing healthcare infrastructure, particularly in emerging markets, there is an expansion of diagnostic laboratories and clinics. This expansion is further augmenting the demand for automated biochemical analyzers to handle the increasing volume of diagnostic tests. However, high cost associated with automated biochemical analyzers, particularly advanced models, restrains the growth of the global market.
Moreover, dearth of of trained laboratory technicians and biomedical engineers to operate and maintain automated biochemical analyzers acts as the key deterrent factor of the market. On the contrary, continuous innovations in automation technology, such as the integration of AI and ML, are improving the performance, accuracy, and efficiency of biochemical analyzers. These advancements help streamline operations in clinical labs and are expected to provide lucrative opportunities for the expansion of the global automated biochemical analyzers market durign the forecast period.
The global automated biochemical analyzers market analysis is segmented into analyzer, application, end user, and region. On the basis of the analyzer, the market is fragmented into biochemistry analyzers, immuno-based analyzers, and hematology analyzers. By application, it is classified into drug discovery, genomics, proteomics, bioanalysis, analytical chemistry, and others. Depending on end user, it is segregated into diagnostic laboratories, pharmaceutical and biotechnology companies, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
On the basis of application, the drug discovery segment is poised to register significant growth during the forecast period.
Depending on end user, the pharmaceutical & biotechnology companies segment is anticipated to exhibit the highest growth by 2033.
Region wise, North America is projected to lead the automated analyzer market in the near future.
An automated biochemical analyzer is a laboratory device designed to conduct biochemical tests on various biologocal samples, including blood, urine, or other bodily fluids, thus serving as an essential part of modern clinical laboratories. These analyzers automate the measurement of chemical components such as glucose, proteins, enzymes, and electrolytes, which are essential for diagnosing diseases, monitoring patient health, and guiding treatment decisions.
The growth of the global automated biochemical analyzers market is majorly driven by alarming increase in incidence of chronic conditions like diabetes, cardiovascular diseases, and kidney disorders. According to a study published by the World Health Organization in September 2023, approximately 41 million individuals die each year due to chronic diseases. This growing patient population necessitates frequent biochemical tests, such as glucose and lipid profile assessments, thus driving the demand for automated biochemical analyzers. Furthermore, surge in geriatric population significantly contributes toward the growth of the global market.
As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050. As the global population ages, there is a growing demand for diagnostic tests to monitor age-related diseases and conditions. Automated biochemical analyzers provide a high-throughput solution to manage the increasing workload in diagnostic laboratories.
In addition, rise in trend toward decentralized healthcare and point-of-care testing has increased the demand for compact, automated biochemical analyzers that can provide rapid results in non-laboratory settings such as clinics and emergency rooms. With the growing healthcare infrastructure, particularly in emerging markets, there is an expansion of diagnostic laboratories and clinics. This expansion is further augmenting the demand for automated biochemical analyzers to handle the increasing volume of diagnostic tests. However, high cost associated with automated biochemical analyzers, particularly advanced models, restrains the growth of the global market.
Moreover, dearth of of trained laboratory technicians and biomedical engineers to operate and maintain automated biochemical analyzers acts as the key deterrent factor of the market. On the contrary, continuous innovations in automation technology, such as the integration of AI and ML, are improving the performance, accuracy, and efficiency of biochemical analyzers. These advancements help streamline operations in clinical labs and are expected to provide lucrative opportunities for the expansion of the global automated biochemical analyzers market durign the forecast period.
The global automated biochemical analyzers market analysis is segmented into analyzer, application, end user, and region. On the basis of the analyzer, the market is fragmented into biochemistry analyzers, immuno-based analyzers, and hematology analyzers. By application, it is classified into drug discovery, genomics, proteomics, bioanalysis, analytical chemistry, and others. Depending on end user, it is segregated into diagnostic laboratories, pharmaceutical and biotechnology companies, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By analyzer, the immuno-based analyzer segment is expected to dominate the global automated biochemical analyzers market from 2024 to 2033.On the basis of application, the drug discovery segment is poised to register significant growth during the forecast period.
Depending on end user, the pharmaceutical & biotechnology companies segment is anticipated to exhibit the highest growth by 2033.
Region wise, North America is projected to lead the automated analyzer market in the near future.
Competition Analysis
Competitive analysis and profiles of the major players in the global automated biochemical analyzers market include Thermo Fisher Scientific, Danaher Corporation, Hudson Robotics Inc., Becton Dickinson and Company, Synchron Lab Automation, Agilent Technologies Inc., Siemens, Tecan Group Ltd., PerkinElmer Inc., and Honeywell International Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.Additional benefits you will get with this purchase are:
- Quarterly Update* (with the purchase of an enterprise license)
- 5 additional Company Profiles, pre- or post-purchase, as a free update.
- Free Updated Version (once released) with the purchase of an enterprise user license.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Analyzer
- Biochemistry Analyzers
- Immuno-Based Analyzers
- Hematology Analyzers
By Application
- Drug Discovery
- Genomics
- Proteomics
- Bioanalyss
- Analytical Chemistry
- Others
By End User
- Diagnostic Laboratories
- Pharmaceutical and Biotechnology Companies
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Hudson Robotics Inc.
- Becton Dickinson and Company
- Synchron Lab Automation
- Agilent Technologies Inc.
- Siemens
- Tecan Group Ltd
- PerkinElmer Inc.
- Honeywell International Inc.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
CHAPTER 4: AUTOMATED BIOCHEMICAL ANALYZERS MARKET, BY ANALYZER
CHAPTER 5: AUTOMATED BIOCHEMICAL ANALYZERS MARKET, BY APPLICATION
CHAPTER 6: AUTOMATED BIOCHEMICAL ANALYZERS MARKET, BY END USER
CHAPTER 7: AUTOMATED BIOCHEMICAL ANALYZERS MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Hudson Robotics Inc.
- Becton Dickinson and Company
- Synchron Lab Automation
- Agilent Technologies Inc.
- Siemens
- Tecan Group Ltd
- PerkinElmer Inc.
- Honeywell International Inc.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 228 |
| Published | August 2024 |
| Forecast Period | 2023 - 2033 |
| Estimated Market Value ( USD | $ 7.6 billion |
| Forecasted Market Value ( USD | $ 24.1 billion |
| Compound Annual Growth Rate | 12.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
